Medications for Polyradiculoneuropathy Chronic Inflammatory Demyelinating

5 results

  • gammaked

    (Immune Globulin (Human))
    KEDRION BIOPHARMA, INC.
    GAMMAKED is indicated for the treatment of primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to improve disability and prevent relapse.

  • gamunex-c

    (Immune Globulin (Human))
    GRIFOLS USA, LLC
    GAMUNEX-C is indicated for treating primary humoral immunodeficiency in patients aged 2 and older, idiopathic thrombocytopenic purpura (ITP) in adults and children, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to enhance neuromuscular function and prevent relapses.

  • hizentra

    (HUMAN IMMUNOGLOBULIN G)
    CSL Behring AG
    HIZENTRA is indicated for the treatment of primary immunodeficiency in patients aged 2 and older, including various humoral immune defects. It is also used as maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability.

  • hyqvia

    (Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase)
    Takeda Pharmaceuticals America, Inc.
    HYQVIA is indicated for treating primary immunodeficiency (PI) in adults and children over two, including conditions like common variable immunodeficiency and Wiskott-Aldrich syndrome. It is also used as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults to prevent relapse of neuromuscular symptoms.

  • vyvgart hytrulo

    (efgartigimod alfa and hyaluronidase (human recombinant))
    argenx US
    VYVGART HYTRULO is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG) who are anti-AChR antibody positive and for chronic inflammatory demyelinating polyneuropathy (CIDP).